Categories AlphaGraphs, Earnings, Technology

Alphabet reverses ad revenue deceleration trend in Q2, stock rises

Alphabet (NASDAQ: GOOG, GOOGL), the parent company of search giant Google, on Thursday reported 19% growth in second-quarter revenues to $38.9 billion, surpassing the Wall Street projection of $38.17 billion. Advertising revenues grew 16%, ending a three- quarter streak of year-over-year growth deceleration.

Despite currency headwinds, adjusted earnings for the quarter grew to $14.21 per share, from $11.75 per share a year ago. This came in far ahead of the street view of $11.30 per share.

googel ad revnue trend

GOOGL shares jumped 6.5% following the earnings announcement. The stock has gained 8% in the year-to-date period, compared to 19.5% gains recorded by the S&P 500 index.

READ: It’s Google 1-0 Amazon in the European Smart Home market

 The company’s Other Revenues segment, which comprises of Google Cloud, Google Play and hardware sales, spiked 40% to $6.18 billion.

alphabet other revenues quarterly growth

In the other bets segment, where the company spends money on new and innovative, but not-yet-profitable operations, revenue improved 11% to $162. Meanwhile, operating losses from this segment widened to $989 million, from $732 million a year ago.

Alphabet (NASDAQ: GOOG, GOOGL) on Thursday reported 19% growth in second-quarter revenues to $38.9 billion, surpassing the Wall Street projection of $38.17 billion.

It’s been a pretty bumpy ride for the Google-parent over the past few weeks.  The US Justice Department recently said it was planning to relaunch an anti-trust probe into the firm. Separately, the calls to break down big tech firms have been louder than ever before.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top